More Articles

US Supreme Court rules against generics delaying tactics Generics/News | Posted 23/04/2012

On 17 April 2012, the US Supreme Court ruled in favour of India-based generics company Sun Pharma in its case against Danish pharmaceutical company, Novo Nordisk, a case that could have provided a...

Australian government urged not to make further cuts to PBS Guidelines | Posted 23/04/2012

In the wake of historically the largest single price cuts to prescription medicines in Australia, both Medicines Australia and the Generic Medicines Industry Association of Australia (GMiA) are urg...

FDA approves generic vancomycin capsules Generics/News | Posted 23/04/2012

On 11 April 2012 India-based Strides Arcolab (Strides) announced that it had received FDA approval for its generic version of Baxter’s antibiotic Vancocin (vancomycin).

Biocon opens new research centre Biosimilars/News | Posted 23/04/2012

Indian biosimilars major Biocon, announced on 5 April 2012 the opening of a new state-of-the-art Integrated Research and Development Centre in Bangalore, India.

EMA publishes procedural advice for biosimilars Biosimilars/News | Posted 13/04/2012

On 11 April 2012, EMA published a new document on regulatory procedural advice for biosimilars.

Cheap generic drug stops fatal bleeding but gets little use Generics/Research | Posted 13/04/2012

According to a systematic review of data, use of a cheap generic drug could potentially save many trauma patients every year [1].

Biosimilars dilemma over reference products Biosimilars/Research | Posted 13/04/2012

Global manufacturers of biosimilars have a dilemma on their hands concerning reference products. What to do to reduce the burden of data required in different countries and regions of the world to...

PhRMA speaks out against compulsory licensing in India Policies & Legislation | Posted 13/04/2012

The decision by the Indian government to issue a compulsory licence for the first time has led the research-based pharmaceutical industry to raise concerns regarding research and innovation.